alexa Sonoporation, anti-cancer drug and antibody delivery using ultrasound.
Materials Science

Materials Science

Journal of Nanomedicine & Nanotechnology

Author(s): Wu J, Pepe J, Rincn M

Abstract Share this page

Abstract It has been shown experimentally in cell suspensions that sonoporation could be used to deliver the anti-cancer drug Adriamycin hydrochloride (ADR) into Jurkat lymphocytes and that it could also be used to deliver goat anti-rabbit IgG and anti-mouse IgD, antibodies into human peripheral blood mononuclear cells (PBMC) and Jurkat lymphocytes. When ADR was delivered, the delivery efficiency reached 4.80+/-2.04\% and control baseline (no ultrasound and no ADR) was 0.17+/-0.14\%. When anti-rabbit IgD was delivered, the efficiencies were 34.90+/-1.80\% (control baseline was 1.33+/-0.31\%) and 32.50+/-4.36\% (control baseline was 1.66+/-0.06\%) respectively for Jurkat cells and PBMC. When goat anti-rabbit IgG was delivered, the efficiencies were 78.60+/-3.60\% (control baseline was 1.60+/-0.00\%) and 57.50+/-4.23\% (control baseline was 11.30+/-0.81\%) respectively for Jurkat cells and PBMC. This article was published in Ultrasonics and referenced in Journal of Nanomedicine & Nanotechnology

Recommended Conferences

  • Nano Congress for Next Generation
    August 31-September 01, 2017 Brussels,Belgium
  • Graphene & 2D Materials
    September 14-15, 2017 Edinburgh, Scotland
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version